SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Josephine Baker — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJosephine Baker
Date of birth1906-06-03
IdentifiersMRN HR-ML049-SYN-TD; SSN (made up) 000-49-3172
Document date1969-07-21
AuthorColette Ashby-Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Twelve-week review: exercise test, lipids, mood and the return to performing. [S]

History of Present Illness

Ms. Baker returns about four months after the heart attack and five weeks after her sick visit for a nosebleed, which has not recurred. She completed all 36 cardiac rehabilitation sessions last week. On the treadmill test today she walked for nine minutes without chest pain or breathlessness. She has been practicing songs and dance steps at home for up to an hour, and she has an offer for a short run of concerts in the autumn. Her home blood pressure averages 122/74. She is sleeping well, her mood is better, and the rehabilitation psychologist helped her with the worry about her family and her debts. She has taken every dose of her medicines. [S]

ElementDetail
RehabilitationAll 36 sessions completed
Exercise testNine minutes, about 10 METs, no angina, no ischemic change
Home blood pressureAverage 122/74 mmHg
MoodPHQ-9 3, from 7
PlansA short run of concerts in the autumn

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain, palpitations or lightheadedness, including during the test
RespiratoryNegativeNo breathlessness
Ears, nose, mouth, and throatNegativeNo further nosebleeds
MusculoskeletalNegativeNo muscle aches on atorvastatin
PsychiatricNegativeMood better; sleeping well

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24activeS
Ticagrelor 90 mg oral tablet, one tablet twice dailyOne tablet twice dailyOral route1969-03-24 to 1969-04-28completedS
Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet dailyOne tablet daily after a 600 mg loading doseOral route1969-04-28activeS
Atorvastatin 80 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24activeS
Lisinopril 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24 to 1969-04-28completedS
Lisinopril 10 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-04-28activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route1969-03-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1969-07-21Body height168cmS
1969-07-21Body weight60.4kgS
1969-07-21Body mass index (BMI) [Ratio]21.4kg/m2S
1969-07-21Systolic blood pressure122mm[Hg]S
1969-07-21Diastolic blood pressure76mm[Hg]S
1969-07-21Heart rate58/minS
1969-07-21Respiratory rate14/minS
1969-07-21Body temperature36.5CelS
1969-07-21Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1969-07-21Cholesterol [Mass/volume] in Serum or Plasma128mg/dL<=199 mg/dLNormalS
1969-07-21Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation62mg/dLSecondary-prevention goal below 70 mg/dLNormalS
1969-07-21Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=50 mg/dLNormalS
1969-07-21Triglyceride [Mass/volume] in Serum or Plasma72mg/dL<=149 mg/dLNormalS
1969-07-21Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-35 U/LNormalS
1969-07-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1969-07-21Overall summary score [SAQ]94{score}S

Physical Exam

Vital signs recorded on 1969-07-21; see the Vital Signs section. [S]

SystemFinding
GeneralWell and energetic; blood pressure 122/76, pulse 58; weight 60.4 kg
CardiovascularRegular rhythm; no murmur
RespiratoryClear
NoseLeft nasal septum healed
ExtremitiesNo edema

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning)resolvedconfirmed R06.09S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology attributed it to ticagrelor.
Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912activeconfirmed I25.10S — Synthetic modern diagnosis; the 1969 heart attack remains D in the history.
High blood pressure, found during the hospital stay for the heart attackactiveconfirmed I10S — Synthetic modern diagnosis; no claim about her real blood pressure.
Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular riskactiveprovisional Z90.710S — Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source.
Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrelresolvedconfirmed T45.525AS — Synthetic diagnosis at the second visit; resolved at the third visit after the switch.
Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factoractiveconfirmed E78.41S — Synthetic result measured once at the second visit.
Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recoversactiveconfirmed Z59.86S — Synthetic social need anchored to her documented debts and the loss of Les Milandes.
Anterior nosebleed from the left side of the nose, lasting about 25 minutes, in dry weather on aspirin and clopidogrel; stopped with pressure; no further bleedingresolvedconfirmed R04.0S — Synthetic intercurrent problem at an unscheduled visit; it follows from dual antiplatelet therapy and does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (seated, average of two readings; home readings)Every visitCompleted today122/76 mmHg; home average 122/74
ExaminationWeight, BMI and physical activityEvery visitCompleted today60.4 kg; rehabilitation completed; practicing up to an hour a day
Medication safetyAdherence: aspirin and P2Y12 inhibitor through the dual antiplatelet window, high-intensity statin, beta-blocker, ACE inhibitorEvery visitCompleted todayNo missed doses
Medication safetyBleeding on dual antiplatelet therapy (symptoms, hemoglobin when indicated)Every visitCompleted todayOne anterior nosebleed five weeks ago, managed without stopping antiplatelets (hemoglobin 11.9 g/dL then); none since
LaboratoryLipid panelFour to eight weeks after a statin start or change, then every three to twelve monthsCompleted todayAbout four months on atorvastatin 80 mg: LDL 62 mg/dL (58% fall from 146), total cholesterol 128, HDL 54, triglycerides 72; ALT 22 U/L. This is the first panel since the check due four to eight weeks after the start was missed; LDL is at goal, so the delay caused no harm and no change in treatment was postponed
LaboratoryMetabolic panel (potassium, creatinine, eGFR) on an ACE inhibitorOne to two weeks after a start or dose change, then every six to twelve monthsUp to datePotassium 4.7, creatinine 0.88 mg/dL eight weeks ago; next at about six months
SurveyDepression screen (PHQ-2, then PHQ-9)After the infarction and periodicallyCompleted todayPHQ-9 3, from 7; item 9 scored 0
SurveyAngina status (Seattle Angina Questionnaire-7)At intake and every few months in the first yearCompleted today94
ExaminationStress testing or repeat angiographyNot for routine surveillance; for exercise prescription or new symptomsCompleted todayExercise test today to prescribe exercise and guide the return to performing: about 10 METs, no angina or ischemic change
ImagingEchocardiogram for left ventricular functionAfter the infarction if not done or if function was reduced; then only with clinical changeNot indicatedNo clinical change
ReferralCardiac rehabilitationWithin weeks of the infarction; 36 sessionsCompleted todayAll 36 sessions completed
Self-managementSelf-management: chest-pain action plan, nitroglycerin, women's warning symptomsEvery visitCompleted todayAction plan reviewed for the dressing room and travel
Medication safetyMedicine and visit costsEvery visitCompleted todayMedicines affordable as generics; repayment plan in place

Goal progress:

Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association (2008); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026)

Follow-up: Preventive visit in about eight weeks. Seven-month review in about three months with a metabolic panel and a blood count. Call 911 for chest pain not relieved five minutes after one nitroglycerin. Next scheduled visit 1969-09-15: periodic adult preventive visit. [S]